drugset / Trial / NCT07647627
Availability of Dibotatug (DR-01) Outside Clinical Trials Via Expanded Access for Eligible Participants
Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to Dibotatug (DR-01). Physician-requested expanded access will generally only be considered for patients not otherwise eligible for an ongoing clinical study sponsored by Dren Bio and provided that other program eligibility criteria are also met.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Dibotatug | Monoclonal antibody | — | — |
Indications
No indication recorded.